Analysts show increased optimism for Nine Dragons Paper (Holdings), upgrading their earnings per share estimates. Despite a revenue estimates downgrade, the business is still expected to outpace the wider industry. The consensus price target remains steady at HK$4.34.
Nine Dragons Paper's consistent share dip and shift to a loss-making stance are red flags for investors. Despite dividends providing some relief, the total shareholder return still suffers. Prolonged share price weakness can suggest inherent company issues.
玖龍紙業股票討論區
專欄港股收評:恆生科技指數跌3%,醫藥、芯片、新能源板塊下挫
今日,港股全天呈下跌行情,市場情緒表現低迷,恆生科技指數大跌3.46%,恆指、$國企指數(800100.HK)$ 分別下跌1.71%和1.96%,恆指下挫近350點,三者齊刷月內新低價。
盤面上,大型科技股全線下跌,$美團-W(03690.HK)$ 、$京東集團-SW(09618.HK)$ 跌超4%,$快手-W(01024.HK)$ 、$小米集團-W(01810.HK)$ 、$百度集團-SW(09888.HK)$ 、$網易-S(09999.HK)$ 、$阿里巴巴-SW(09988.HK)$ 皆跌超3%;
生物醫藥股領跌市場,藥明康德重挫超10%;此前消息稱拜登政府欲限制美企對華投資,半導體股連續下跌,且午後跌幅擴大明顯;特斯拉概念股、鋰電池股、光伏股等新能源股跌幅靠前,濠賭股、軍工...
暫無評論